EpiPens
The CEO of Mylan Pharmaceuticals spent most of Wednesday answering tough questions about the price hike for their EpiPens. This time, Heather Bresch was being grilled by colleagues of her father, Senator Joe Manchin. Bresch told the House Committee on Oversight and Government Reform that the cost increase for the lifesaving medication was justified.